STOCK TITAN

[Form 4] ClearSign Technologies Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

ClearSign Technologies (CLIR) reported a director equity transaction. On 10/01/2025, a non‑executive director acquired 24,621 restricted stock units (RSUs) at $0.00 under the company’s 2021 Equity Incentive Plan as compensation for the quarter ending December 31, 2025.

The RSUs vest upon the first to occur of a change in control, disability, death, or separation from service. After this grant, the reporting person directly beneficially owned 70,266 derivative securities.

ClearSign Technologies (CLIR) ha riportato una transazione azionaria da parte di un amministratore. Il 01/10/2025, un amministratore non esecutivo ha acquisito 24.621 unità azionarie soggette a restrizioni (RSU) a $0,00 nell’ambito del piano di incentivazione azionaria 2021 dell’azienda come compenso per il trimestre conclusosi il 31 dicembre 2025.

Le RSU maturano al verificarsi della prima delle seguenti ipotesi: cambiamento di controllo, disabilità, morte o separazione dal servizio. Dopo questa assegnazione, la persona che segnala deteneva direttamente 70.266 strumenti derivati.

ClearSign Technologies (CLIR) informó una transacción de equidad de un director. El 01/10/2025, un director no ejecutivo adquirió 24,621 unidades de acciones restringidas (RSU) a $0,00 como compensación por el trimestre que terminó el 31 de diciembre de 2025.

Las RSU se visten al primero que ocurra de un cambio en el control, discapacidad, muerte o separación del servicio. Después de este otorgamiento, la persona informante poseía directamente 70,266 valores derivados.

ClearSign Technologies (CLIR) 이사 지분 거래를 보고했습니다. 2025년 10월 1일에, 비경영 이사가 24,621주의 제한 주식 단위(RSUs)$0.00의 보상으로 2025년 12월 31일로 끝나는 분기에 대해 취득했습니다.

RSU는 지배권 변경, 장애, 사망 또는 서비스 종료 중 최초로 발생하는 경우에 vest됩니다. 이 수여 이후, 보고자는 직접 유익하게 70,266 파생 증권을 보유하게 되었습니다.

ClearSign Technologies (CLIR) a rapporté une transaction d’actions par un administrateur. Le 01/10/2025, un administrateur non exécutif a acquis 24 621 unités d’actions restreintes (RSU) pour $0,00 dans le cadre du Plan d’incitation à actions 2021 de la société en tant que compensation pour le trimestre se terminant le 31 décembre 2025.

Les RSU deviennent acquis lors du premier cas parmi les suivants: changement de contrôle, invalidité, décès ou rupture de service. Après cette attribution, la personne déclarante détenait directement 70 266 titres derivés.

ClearSign Technologies (CLIR) berichtete eine Transaktion von Vorzugsaktien eines Direktors. Am 01.10.2025 erwarb ein nicht geschäftsführender Direktor 24.621 eingeschränkte Aktieneinheiten (RSUs) im Rahmen des Equity Incentive Plans 2021 des Unternehmens als Vergütung für das Quartal, das am 31.12.2025 endete.

Die RSUs vesten, sobald der erste der folgenden Fälle eintritt: eine Änderung der Kontrolle, Behinderung, Tod oder Trennung vom Dienst. Nach dieser Gewährung war die meldende Person direkt vorteilhaft Eigentümer von 70.266 Derivaten.

ClearSign Technologies (CLIR) أبلغ عن صفقة أسهم لمدير. في 01/10/2025، اشترى مدير غير تنفيذي 24,621 وحدة أسهم مقيدة (RSU) بسعر $0.00 كتعويض بموجب خطة الحوافز بالأسهم لعام 2021 للشركة عن الربع المنتهي في 31 ديسمبر 2025.

تُستوى RSU عند حدوث أول تغيير في السيطرة، الإعاقة، الوفاة، أو الانفصال عن الخدمة. بعد هذه المنحة، امتلك الشخص المبلغ عنه مباشرةً 70,266 ورقة مشتقة.

ClearSign Technologies (CLIR) 报告了一项董事交易。在2025/10/01,一名非执行董事在公司2021年股权激励计划下以$0.00获得了24,621份受限股票单位(RSU),作为截至2025年12月31日季度的补偿。

RSU在以下任一事件发生时生效:控制权变更、残疾、死亡或离职。该授予之后,汇报人直接受益拥有70,266份衍生证券

Positive
  • None.
Negative
  • None.

Insights

Routine director RSU grant; neutral impact.

ClearSign Technologies reported a director equity award of 24,621 RSUs on 10/01/2025 at $0.00 (standard for RSUs). This aligns with customary board compensation and does not itself change cash balances.

Vesting is contingent on specified events: Change in Control, Disability, death, or separation from service, as described. Post-transaction holdings show 70,266 derivative securities beneficially owned directly.

This filing records equity compensation and ownership. Actual impact depends on vesting events and future share delivery mechanics disclosed in subsequent company materials.

ClearSign Technologies (CLIR) ha riportato una transazione azionaria da parte di un amministratore. Il 01/10/2025, un amministratore non esecutivo ha acquisito 24.621 unità azionarie soggette a restrizioni (RSU) a $0,00 nell’ambito del piano di incentivazione azionaria 2021 dell’azienda come compenso per il trimestre conclusosi il 31 dicembre 2025.

Le RSU maturano al verificarsi della prima delle seguenti ipotesi: cambiamento di controllo, disabilità, morte o separazione dal servizio. Dopo questa assegnazione, la persona che segnala deteneva direttamente 70.266 strumenti derivati.

ClearSign Technologies (CLIR) informó una transacción de equidad de un director. El 01/10/2025, un director no ejecutivo adquirió 24,621 unidades de acciones restringidas (RSU) a $0,00 como compensación por el trimestre que terminó el 31 de diciembre de 2025.

Las RSU se visten al primero que ocurra de un cambio en el control, discapacidad, muerte o separación del servicio. Después de este otorgamiento, la persona informante poseía directamente 70,266 valores derivados.

ClearSign Technologies (CLIR) 이사 지분 거래를 보고했습니다. 2025년 10월 1일에, 비경영 이사가 24,621주의 제한 주식 단위(RSUs)$0.00의 보상으로 2025년 12월 31일로 끝나는 분기에 대해 취득했습니다.

RSU는 지배권 변경, 장애, 사망 또는 서비스 종료 중 최초로 발생하는 경우에 vest됩니다. 이 수여 이후, 보고자는 직접 유익하게 70,266 파생 증권을 보유하게 되었습니다.

ClearSign Technologies (CLIR) a rapporté une transaction d’actions par un administrateur. Le 01/10/2025, un administrateur non exécutif a acquis 24 621 unités d’actions restreintes (RSU) pour $0,00 dans le cadre du Plan d’incitation à actions 2021 de la société en tant que compensation pour le trimestre se terminant le 31 décembre 2025.

Les RSU deviennent acquis lors du premier cas parmi les suivants: changement de contrôle, invalidité, décès ou rupture de service. Après cette attribution, la personne déclarante détenait directement 70 266 titres derivés.

ClearSign Technologies (CLIR) berichtete eine Transaktion von Vorzugsaktien eines Direktors. Am 01.10.2025 erwarb ein nicht geschäftsführender Direktor 24.621 eingeschränkte Aktieneinheiten (RSUs) im Rahmen des Equity Incentive Plans 2021 des Unternehmens als Vergütung für das Quartal, das am 31.12.2025 endete.

Die RSUs vesten, sobald der erste der folgenden Fälle eintritt: eine Änderung der Kontrolle, Behinderung, Tod oder Trennung vom Dienst. Nach dieser Gewährung war die meldende Person direkt vorteilhaft Eigentümer von 70.266 Derivaten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Basenese Lou

(Last) (First) (Middle)
8023 E. 63RD PLACE, SUITE 101

(Street)
TULSA OK 74133

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ClearSign Technologies Corp [ CLIR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/01/2025 A 24,621 (2) (2) Common Stock 24,621 $0.00 70,266 D
Explanation of Responses:
1. As compensation for services as a non-executive director during the quarter ending December 31, 2025, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
2. The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting person's death; or (4) the reporting person's separation from service.
/s/ Louis J. Basenese 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CLIR disclose in this Form 4?

A director acquired 24,621 RSUs on 10/01/2025 at $0.00 as part of quarterly director compensation under the 2021 Equity Incentive Plan.

How many RSUs were granted to the CLIR director and at what price?

The grant was for 24,621 RSUs at an RSU price of $0.00.

What are the vesting conditions for the RSUs reported by CLIR?

They vest upon the first to occur of change in control, disability, death, or separation from service.

What is the director’s derivative holdings after the transaction?

Following the transaction, the director directly beneficially owned 70,266 derivative securities.

What plan governs the RSU grant reported by CLIR?

The grant was made under the ClearSign Technologies Corporation 2021 Equity Incentive Plan.

What is the relationship of the reporting person to CLIR?

The reporting person is a Director of ClearSign Technologies.
Clearsign Technologies Corp

NASDAQ:CLIR

CLIR Rankings

CLIR Latest News

CLIR Latest SEC Filings

CLIR Stock Data

45.62M
41.07M
5.56%
24.74%
0.41%
Pollution & Treatment Controls
Industrial Instruments for Measurement, Display, and Control
Link
United States
TULSA